This pharmacological agent, initially developed for the management of type 2 diabetes mellitus , has shown promising results in weight loss, sparking interest and debate in medicine
While Vafseo is now approved in 37 countries, the FDA did give the oral prolyl hydroxylase inhibitor a boxed warning over a heightened risk of death, stroke, myocardial infection, venous thromboembolism and thrombosis of vascular access
brand names can exceed $1,000/month if not covered by a third-party (which Hers doesnt process) Is Hers worth it
community use is SubQ with unknown bioavailability differences
Pregnancy Talk to your doctor if you are pregnant or plan to become pregnant
Stalled weight loss can easily be attributed to low amounts of calories burned through scant physical activity, whether youre on semaglutide or not